BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25342321)

  • 1. Effects of SC-560 in combination with cisplatin or taxol on angiogenesis in human ovarian cancer xenografts.
    Li W; Wan L; Zhai LY; Wang J
    Int J Mol Sci; 2014 Oct; 15(10):19265-80. PubMed ID: 25342321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a cyclooxygenase-1-selective inhibitor in a mouse model of ovarian cancer, administered alone or in combination with ibuprofen, a nonselective cyclooxygenase inhibitor.
    Li W; Xu RJ; Lin ZY; Zhuo GC; Zhang HH
    Med Oncol; 2009; 26(2):170-7. PubMed ID: 18988002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor properties of taxol in combination with cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on ovarian tumor growth in vivo.
    Li W; Zhai L; Tang Y; Cai J; Liu M; Zhang J
    Oncol Res; 2012; 20(2-3):49-59. PubMed ID: 23193911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice.
    Li W; Ji ZL; Zhuo GC; Xu RJ; Wang J; Jiang HR
    Med Oncol; 2010 Mar; 27(1):98-104. PubMed ID: 19235530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y; Xin B; Shigeto T; Mizunuma H
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1219-28. PubMed ID: 21681689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer.
    Wang L; Chen W; Xie X; He Y; Bai X
    Exp Oncol; 2008 Mar; 30(1):42-51. PubMed ID: 18438340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cyclooxygenase inhibitors in combination with taxol on expression of cyclin D1 and Ki-67 in a xenograft model of ovarian carcinoma.
    Li W; Cai JH; Zhang J; Tang YX; Wan L
    Int J Mol Sci; 2012; 13(8):9741-9753. PubMed ID: 22949827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combining Taxol and cyclooxygenase inhibitors on the angiogenesis and apoptosis in human ovarian cancer xenografts.
    Li W; Tang YX; Wan L; Cai JH; Zhang J
    Oncol Lett; 2013 Mar; 5(3):923-928. PubMed ID: 23426648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of a selective cyclooxygenase-2 inhibitor with epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 and protein kinase A antisense causes cooperative antitumor and antiangiogenic effect.
    Tortora G; Caputo R; Damiano V; Melisi D; Bianco R; Fontanini G; Veneziani BM; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2003 Apr; 9(4):1566-72. PubMed ID: 12684433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
    Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
    Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Inhibitor of Differentiation-1 and Its Effects on Angiogenesis in Gastric Cancer.
    Li DN; Wang L; Wang L; Li S; Wang YB
    Cancer Biother Radiopharm; 2016 Sep; 31(7):233-7. PubMed ID: 27610466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer.
    Xu TM; Xin Y; Cui MH; Jiang X; Gu LP
    Chin Med J (Engl); 2007 Apr; 120(7):584-8. PubMed ID: 17442207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.
    Ghosh S; Maity P
    J Environ Pathol Toxicol Oncol; 2010; 29(1):17-30. PubMed ID: 20528744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Influence of rosiglitazone and all-trans-retinoic acid on angiogenesis and growth of myeloma xenograft in nude mice].
    Huang HW; Chen P; Li BZ; Fu JX; Li J; Zhang XH; Liu R; Fan YY; Zhang H; Chow HC; Leung AY; Liang R
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):652-7. PubMed ID: 23159076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
    RosanĂ² L; Spinella F; Salani D; Di Castro V; Venuti A; Nicotra MR; Natali PG; Bagnato A
    Cancer Res; 2003 May; 63(10):2447-53. PubMed ID: 12750265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined trastuzumab and paclitaxel treatment better inhibits ErbB-2-mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone.
    Klos KS; Zhou X; Lee S; Zhang L; Yang W; Nagata Y; Yu D
    Cancer; 2003 Oct; 98(7):1377-85. PubMed ID: 14508823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the combination of a cyclooxygenase-1 selective inhibitor and taxol on proliferation, apoptosis and angiogenesis of ovarian cancer in vivo.
    Li W; Liu ML; Cai JH; Tang YX; Zhai LY; Zhang J
    Oncol Lett; 2012 Jul; 4(1):168-174. PubMed ID: 22807982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of IL-24 and cisplatin inhibits angiogenesis and lymphangiogenesis of cervical cancer xenografts in a nude mouse model by inhibiting VEGF, VEGF-C and PDGF-B.
    Wang Z; Lv J; Zhang T
    Oncol Rep; 2015 May; 33(5):2468-76. PubMed ID: 25778843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ; Chen CQ; Zhao ZM; Sun W
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.